LO
LOTWW
Lotus Technology Inc.
$0.0700
0.00%
$37.3M
No data for this timeframe.
Vol
Market Cap$37.3M
Cap SizeNano Cap
Inst. Holders1 funds
Inst. Value$4.00
Inst. Activity0 buys / 1 sells
SEC Reports2
Exchange Nasdaq·Sector Motor Vehicles & Passenger Car Bodies·Inc. E9·CIK 0001962746·Prev Close $0.0700
Recent Activity
Jun 3, 2026
SEC
Lotus Technology Inc. announced a change in board composition: Mr. Joe Quan Zhang was appointed as a member and chairman
6-K — Impact 3/10
May 12, 2026
SEC
Lotus Technology announced its 'Focus 2030' strategic plan, emphasizing a multi-powertrain approach (ICE, PHEV, BEV) wit
6-K — Impact 4/10
Inst.
UBS Group AG — TRIM
582 shares ($41.00)
Inst.
UBS Group AG — ADD
2,216 shares ($222.00)
Latest Reports
NEUTRAL
6-K
3/10
Lotus Technology Inc. announced a change in board composition: Mr. Joe Quan Zhang was appointed as a member and chairman
Jun 3, 2026
NEUTRAL
6-K
4/10
Lotus Technology announced its 'Focus 2030' strategic plan, emphasizing a multi-powertrain approach (ICE, PHEV, BEV) wit
May 12, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| WELLS FARGO & COMPANY/MN | $4.00 | — |
1 institutional holders with $4.00 total value (78 shares) as of 2025-Q4. Top holders: WELLS.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | WELLS FARGO & COMPANY/MN | 78 | $4.00 | 100.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | TRIM | 2,216 | 582 | -73.7% | $41.00 | 2025-Q3 |
| UBS Group AG | ADD | 1,124 | 2,216 | +97.2% | $222.00 | 2025-Q2 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
2 SEC filing reports analyzed. Sentiment: 0 bullish, 0 bearish, 0 mixed, 2 neutral. Avg impact: 3.5/10.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Next Q 2026-06-30 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | — | — |
| Current Q 2026-03-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.1B | — | — |
| Current FY 2026-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.7B | 40.3% | — |
| Next FY 2027-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $1.4B | 88.1% | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.